![Editors in Conversation artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts113/v4/b8/68/dd/b868dd9f-5a51-91c9-fb51-f8d1567e8465/mza_5151066038574592298.jpg/100x100bb.jpg)
Management of Mycobacterium Abscessus Infections: The Rise of a Superbug (AAC ed.)
Editors in Conversation
English - September 02, 2022 09:00 - 42 minutes - 29.2 MB - ★★★★ - 10 ratingsLife Sciences Science Health & Fitness Medicine asm for fox interviews jeff magazine microbe microbiology news science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The Inoculum Effect of Antibiotic Susceptibility Testing
Infections caused by Mycobacterium abscessus appear to be increasing in frequency among the immunocompromised population and are challenging to treat. Antibiotic options in these cases are scarce, prolonged therapy is required and new options are needed. We will discuss this important topic with experts in the field.
Topics discussed: Define M. abscessus as an opportunistic pathoge The intrinsic phenotypic characteristics of M. abscessus, including resistance to common antimicrobials Treatment approaches and rationale for these strategies Guests: Kelly Dooley, MD. PhD, MPH. Professor of Medicine, Johns Hopkins University and Editor of AAC Charles L. Daley, MD, Professor and Chief of the Division of Mycobacterial and Respiratory Infections. National Jewish Health Thomas Dick, PhD. Professor, Center for Discovery and Innovation, Hackensack Meridian HealthThis episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up
Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.